Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies

European Journal of Cancer

Volumn 47, Issue 3, 2011, Pages 375-382

  Courrech Staal, Ewout F W ^a   Smit, Vincent T H B M ^b   Van Velthuysen, Marie Louise F ^a   Spitzer Naaykens, Juliette M J ^c   Wouters, Michel W J M ^a,b   Mesker, Wilma E ^b   Tollenaar, Rob A E M ^b   Van Sandick, Johanna W ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Reinier de Graaf Gasthuis ^*  (Netherlands)

Author keywords

Adenocarcinoma; Interobserver agreement; Intraobserver agreement; Oesophageal cancer; Prognosis; Stroma

Indexed keywords

ADJUVANT THERAPY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SCORING SYSTEM; STROMA; TISSUE SECTION; TUMOR BIOPSY; TUMOR STROMA RATIO;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PROGNOSIS;

EID: 79251600263     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.09.043     Document Type: Article

References (23)

1. H.J. Stein, and J.R. Siewert Improved prognosis of resected esophageal cancer World J Surg 28 2004 520 525
2. I. Rouvelas, W. Zeng, and M. Lindblad Survival after surgery for oesophageal cancer: a population-based study Lancet Oncol 6 2005 864 870
3. P.C. Enzinger, and R.J. Mayer Esophageal cancer N Engl J Med 349 2003 2241 2252
4. J.R. Siewert, M. Feith, M. Werner, and H.J. Stein Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients Ann Surg 232 2000 353 361
5. T. Lerut, P. Nafteux, and J. Moons Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma Ann Surg 240 2004 962 972
6. J.M. Omloo, S.M. Lagarde, and J.B. Hulscher Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial Ann Surg 246 2007 992 1000
7. S.M. Lagarde, F.J. Ten Kate, and D.J. de Boer Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction Am J Surg Pathol 30 2006 171 176
8. S.M. Lagarde, P.E. Ver Loren van Themaat, and P.D. Moerland Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus Ann Surg Oncol 15 2008 3459 3470
9. N. Wernert The multiple roles of tumour stroma Virchows Arch 430 1997 433 443
10. S.M. Pupa, S. Menard, S. Forti, and E. Tagliabue New insights into the role of extracellular matrix during tumor onset and progression J Cell Physiol 192 2002 259 267
11. O. De Wever, and M. Mareel Role of tissue stroma in cancer cell invasion J Pathol 200 2003 429 447
12. W.E. Mesker, J.M. Junggeburt, and K. Szuhai The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage Cell Oncol 29 2007 387 398
13. W.E. Mesker, G.J. Liefers, and J.M. Junggeburt Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients Cell Oncol 31 2009 169 178
14. de Kruijf EM, van Nes JG, van de Velde CJ, et al. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat 2010 [Epub ahead of print].
15. E.F. Courrech Staal, M.W. Wouters, and J.W. van Sandick The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy? Eur J Cancer 46 2010 720 728
16. L.H. Sobin, and C. Wittekind TNM classification of malignant tumours 6th ed. 2002 Wiley-Liss New York
17. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
18. A.M. Maeshima, T. Niki, and A. Maeshima Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma Cancer 95 2002 2546 2554
19. H. Breuninger, G. Schaumburg-Lever, J. Holzschuh, and H.P. Horny Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer Cancer 79 1997 915 919
20. N. Yanagisawa, R. Li, and D. Rowley Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy Hum Pathol 38 2007 1611 1620
21. T. Tsujino, I. Seshimo, and H. Yamamoto Stromal myofibroblasts predict disease recurrence for colorectal cancer Clin Cancer Res 13 2007 2082 2090
22. N.P. West, M. Dattani, and P. McShane The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients Br J Cancer 102 2010 1519 1523
23. M.M. Mueller, and N.E. Fusenig Friends or foes - bipolar effects of the tumour stroma in cancer Nat Rev Cancer 4 2004 839 849